• In recent days, Leidos Holdings, Inc. announced two new U.S. defense health and cyber contracts: a US$301,000,000, five-year Army network monitoring agreement and a US$56,000,000, 66‑month Naval Health Research Center award for behavioral health research and operational assessments.
• Together, these wins highlight how Leidos is tying advanced AI-enabled cyber defense with data-driven psychological health work, deepening its role in supporting military readiness across both digital and human domains.
• We’ll now examine how this new AI-enabled Army cyber defense contract could influence Leidos’ existing investment narrative around defense and digital transformation.

Capitalize on the AI infrastructure supercycle with our selection of the 55 best 'picks and shovels' of the AI gold rush converting record-breaking demand into massive cash flow.

Leidos Holdings Investment Narrative Recap

To own Leidos, you generally need to believe in its role as a long term partner for U.S. defense, intelligence, and health agencies, especially in AI-enabled cyber and mission systems. The new Army cyber and Naval Health contracts reinforce that thesis but do not materially change the near term picture, where the key catalyst remains converting its large federal pipeline into higher margin digital work, and the biggest risk is concentrated exposure to shifting U.S. government funding priorities.

The US$301,000,000, five year Army cyber defense award is most relevant here, because it directly links to Leidos’ NorthStar 2030 focus on digital transformation and AI-driven defensive cyber. Together with its broader AI alliances and platforms, this contract sits squarely within the consensus catalyst that higher quality, software heavy federal work can support better margins over time, while also highlighting competitive and pricing risks as more traditional and non-traditional vendors chase similar AI-enabled contracts.

Yet behind these wins, investors should still be aware of how heavily Leidos relies on U.S. government budgets and...

Leidos Holdings' narrative projects $20.7 billion revenue and $1.6 billion earnings by 2029. This requires 5.4% yearly revenue growth and an earnings increase of about $0.2 billion from $1.4 billion today.

Uncover how Leidos Holdings' forecasts yield a $156.60 fair value, a 12% upside to its current price.

Exploring Other Perspectives

Some of the lowest ranked analysts were assuming only about US$19.7 billion of revenue and US$1.6 billion of earnings by 2029, so compared with the more constructive consensus view on AI-driven federal demand, they paint a much more cautious picture that this latest Army cyber win, and the broader US$24 billion cyber pipeline, may ultimately test or even reshape.

Explore 3 other fair value estimates on Leidos Holdings - why the stock might be worth over 2x more than the current price!

Form Your Own Verdict

Don't just follow the ticker - dig into the data and build a conviction that's truly your own.

• A great starting point for your Leidos Holdings research is our analysis highlighting 3 key rewards and 2 important warning signs that could impact your investment decision.
• Our free Leidos Holdings research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Leidos Holdings' overall financial health at a glance.

Want Some Alternatives?

Opportunities like this don't last. These are today's most promising picks. Check them out now:

• Find 46 companies with promising cash flow potential yet trading below their fair value.
• The best AI stocks today may lie beyond giants like Nvidia and Microsoft. Find the next big opportunity with these 18 smaller AI-focused companies with strong growth potential through early-stage innovation in machine learning, automation, and data intelligence that could fund your retirement.
• Explore 24 top quantum computing companies leading the revolution in next-gen technology and shaping the future with breakthroughs in quantum algorithms, superconducting qubits, and cutting-edge research.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.